Illumina Inc
NASDAQ: ILMN
$131.85
-$2.54 (-1.9%)
Real Time Data Delayed 15 Min.
ILMN Articles
Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In a new research report, Cowen highlights upcoming catalysts that could send some...
Published:
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Friday, January 17.
Published:
Jim Henderson, via Wikimedia CommonsThe 2013 annual Nasdaq rebalance occurs on the close Friday December 20 (triple witching date as well as rebalance date for other indices in the U.S.). During this...
Published:
Jon OggNow that stocks have pulled back and interest rates have risen, investors are looking for more guidance on which stocks they should still buy and which stocks they should sell or avoid. 24/7...
Published:
ThinkstockBiotech investing has always proven to be a slippery slope. It is one thing to own one of the large-cap biotech stocks, but it can be a challenge when looking for the stocks that have the...
Published:
Last Updated:
ThinkstockThe world’s second largest maker of laboratory equipment, Thermo Fisher Scientific Inc. (NYSE: TMO) has agree to acquire competitor Life Technologies Corp. (NASDAQ: LIFE) for $13.6...
Published:
Last Updated:
Jon OggThese are some of this Friday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Air Lease Corp. (NYSE: AL) named Bull of the Day as “earnings takeoff”...
Published:
Last Updated:
ThinkstockThere are big movers in the market just about every day, and these movers often come from biotech and other emerging health care winners and losers. The daily direction of the broad market...
Published:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research firms this Friday. Bank of New York Mellon Corp. (NYSE: BK) cut to Neutral at Citigroup....
Published:
Last Updated:
ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena...
Published:
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals...
Published:
Last Updated:
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Friday. Applied Materials Inc. (NASDAQ: AMAT) maintained Buy with $16 target after...
Published:
Tuesday has two merger rumors out from reports today and the shares are surging on the news. We are seeing MetroPCS Communications Inc. (NYSE: PCS) and Illumina Inc. (NASDAQ: ILMN) on the run so far...
Published:
Last Updated:
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement date....
Published: